Alirocumab - Regeneron/Sanofi
At a glance
- Drug Originator Regeneron Pharmaceuticals; sanofi-aventis
- Drug Class Antihyperlipidaemics; Monoclonal antibodies; Vascular disorder therapies
- Mechanism of Action PCSK9 protein inhibitors
- USA Patent Applicants REGENERON PHARMACEUTICALS
- USA Patents 24
- BLAs 1
- International Patents 330
Disclaimer